Paxlovid CAS: 2628280-40-8

CAS NO: 2628280-40-8
Paxlovid
Chemical Name: Paxlovid
Molecular Formula: C23H32F3N5O4
Formula Weight: 499.53
CAS No.: 2628280-40-8
Description Review
Description

Paxlovid is a medication used to treat COVID-19 infections in individuals who are at high risk for severe illness. It is a combination of two drugs, nirmatrelvir and ritonavir. Paxlovid was granted Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA) in 2021 and has been used in clinical settings to treat COVID-19.

Chemical Name

Paxlovid's chemical name is a combination of nirmatrelvir and ritonavir.

Molecular Formula

The molecular formula of nirmatrelvir is C46H65F3N6O5S2, and the molecular formula of ritonavir is C37H48N6O5S2.

Formula Weight

The formula weight of nirmatrelvir is 894.11 g/mol, and the formula weight of ritonavir is 720.96 g/mol.

CAS No.

Paxlovid's CAS number is 2628280-40-8.

Top Ten Keywords and Synonyms from Google

  1. COVID-19
  2. SARS-CoV-2
  3. Antiviral medication
  4. Emergency Use Authorization
  5. High-risk individuals
  6. Nirmatrelvir
  7. Ritonavir
  8. Combination therapy
  9. Pfizer Inc.
  10. Protease inhibitor

Health Benefits of Paxlovid

Paxlovid is used to treat individuals with COVID-19 infections who are at high risk for severe illness. Clinical trials have shown that it can significantly reduce the risk of hospitalization or death in these individuals. This medication works by inhibiting the SARS-CoV-2 virus's ability to replicate in the body, reducing the severity of symptoms and the risk of complications.

Potential Effects

Paxlovid has several potential effects, including:

  1. Antiviral: Paxlovid inhibits the replication of the SARS-CoV-2 virus, reducing its ability to spread and cause severe illness.
  2. Reduction of hospitalizations: Paxlovid has been shown to significantly reduce the risk of hospitalization or death in individuals with COVID-19 infections.
  3. Symptom improvement: Paxlovid can improve symptoms such as fever, cough, and shortness of breath in individuals with COVID-19 infections.

Product Mechanism

Paxlovid is a combination of two drugs, nirmatrelvir and ritonavir. Nirmatrelvir is a protease inhibitor that specifically targets the SARS-CoV-2 virus's main protease, which is essential for viral replication. Ritonavir is a protease inhibitor that enhances the activity of nirmatrelvir in the body, increasing its effectiveness against the SARS-CoV-2 virus.

Safety

Paxlovid is generally safe when taken as prescribed. However, it is not recommended for use in individuals with a history of severe liver or kidney disease. Rare cases of allergic reactions have been reported with the use of Paxlovid. Individuals who experience symptoms such as difficulty breathing, swelling of the face or throat, or rash should seek medical attention immediately.

Side Effects

Paxlovid may cause side effects, including:

  1. Diarrhea
  2. Nausea
  3. Headache
  4. Fatigue
  5. Abdominal pain
  6. Dizziness
  7. Rash
  8. Vomiting
  9. Constipation
  10. Elevated liver enzymes

Dosing Information

The dosing of Paxlovid varies depending on the individual's age and weight. It is usually prescribed as four tablets taken together twice daily for five days. Paxlovid should be taken with food to improve absorption.

Conclusion

Paxlovid is an antiviral medication used to treat individuals with COVID-19 infections who are at high risk for severe illness. It is a combination of two drugs, nirmatrelvir and ritonavir, that work together to inhibit the SARS-CoV-2 virus's ability to replicate in the body. Paxlovid has been shown to significantly reduce the risk of hospitalization or death in individuals with COVID-19 infections. While generally safe, it may cause side effects or allergic reactions in some individuals. If you are experiencing symptoms of COVID-19, it is important to seek medical attention and follow the guidance of healthcare professionals

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code